Evaluating the correlation between early and late quality-of-life declines using the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) after definitive stereotactic body radiotherapy, intensity-modulated radiotherapy, or brachytherapy for prostate cancer.

Jacob Samuel Parzen,Thomas J Quinn,Andrew B Thompson,Peter Chang,Sean P. Collins,Simeng Suy,Jeff M. Michalski,Constantine Mantz,Zachary A. Seymour,Daniel A. Hamstra

Evaluating the correlation between early and late quality-of-life declines using the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) after definitive stereotactic body radiotherapy, intensity-modulated radiotherapy, or brachytherapy for prostate cancer.

2021

Jacob Samuel Parzen
Thomas J Quinn
Andrew B Thompson
Peter Chang
Sean P. Collins
Simeng Suy
Jeff M. Michalski
Constantine Mantz
Zachary A. Seymour
Daniel A. Hamstra

214Background: Multiple authorities including an NCI Taskforce have recommended routine evaluation of patient reported outcomes (PRO) in cancer care.The Expanded Prostate Cancer Index Composite for...

Keywords:

EPIC
Quality of life
Prostate cancer
Clinical Practice
Brachytherapy
Cancer
intensity modulated radiotherapy
Radiology
Expanded Prostate Cancer Index Composite
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations